Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
This Month's Highlights
You have accessRestricted Access

This Month’s Highlights

JASN November 2007, 18 (11) F3; DOI: https://doi.org/10.1681/ASN.2007080961
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

BASIC RESEARCH

Mechanism of IFN-β’s Antiproteinuric Effect

IFN-β, an immunomodulatory cytokine, has been shown to reduce proteinuria, improve renal function, and prolong survival in a mouse model of lupus. Satchell and colleagues report that IFN-β significantly reduces proteinuria in three rat models of glomerulonephritis, but this does not seem to be a result of reduced glomerular inflammation. Instead, IFN-β decreases albumin flux and increases electrical resistance across glomerular endothelial cells and podocytes. They suggest that IFN-β may hold promise for the treatment of proteinuric renal diseases, in part by tightening the glomerular filtration barrier. See Satchell et al., pages 2875–2884.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Glycocalyx Contributes to Glomerular Permselectivity

Glycocalyx coats the luminal surface of all endothelia. Singh and colleagues confirm the presence of a 200-nm coat of glycocalyx on conditionally immortalized human glomerular endothelial cells. Incubation with heparanase, which degrades a component of the glycocalyx, increases albumin flux across these cells but does not affect transcellular passage of water and solute. Therefore, glycocalyx seems to contribute to the selective permeability of the glomerular basement membrane, and heparanase may contribute to the pathogenesis of proteinuric renal disease by disturbing this barrier. See Singh et al., pages 2885–2893.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Renoprotective Stem Cells Secrete IGF-1

Administration of bone marrow–derived mesenchymal stem cells improves renal structure and function in mice with cisplatin-induced kidney injury. Coculture experiments by Imberti and colleagues demonstrate that IGF-1 produced by stem cells protects cisplatin-treated proximal tubule cells by promoting cellular proliferation and reducing apoptosis. In mice, this renoprotective effect was removed when the IGF-1 gene was silenced. Mesenchymal stem cells may be used to treat acute kidney injury in the future, and their beneficial effect may result, in part, from the release of IGF-1 in the damaged microenvironment. See Imberti et al., pages 2921–2928.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

CLINICAL EPIDEMIOLOGY

Race, HIV, and ESRD

Little is known about the risk of ESRD among patients infected with the HIV. Choi and colleagues analyzed data from >2 million U.S. veterans and report that diabetes and HIV confer similar increased risks of ESRD among blacks. Among whites, diabetes was associated with an increased risk of ESRD but HIV was not. In addition, the age- and sex-adjusted incidence of ESRD was nearly 10 times higher among HIV-infected blacks than HIV-infected whites. These findings should encourage new strategies to treat renal disease among HIV-infected blacks. See Choi et al., pages 2968–2974.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

CLINICAL RESEARCH

PTH Levels Predict Vascular Damage in Children

Cardiovascular disease is the most common cause of death among young adults with chronic kidney disease. Shroff and colleagues report that children with ESRD and levels of PTH more than twice the upper limit of normal have greater carotid intima-media thickness, stiffer vessels, and increased cardiac calcification compared with age-matched controls. A strong dose-dependent correlation exists between vitamin D therapy and all vascular measures. Although causation cannot be claimed from this observational study, uncontrolled secondary hyperparathyroidism and exogenous vitamin D may contribute to vascular damage and calcification among children on dialysis. See Shroff et al., pages 2996–3003.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Thin Basement Membrane Nephropathy Isn’t Always Benign

Classic teaching suggests that thin basement membrane nephropathy carries an excellent prognosis. Voskarides and colleagues diagnosed concomitant FSGS and thin basement membrane nephropathy in 20 renal biopsies from 13 families. In 10 of these families, the authors identified mutations in the COL4A3/COL4A4 locus. Of 82 patients harboring mutations, 38% developed chronic renal failure, and 20% developed ESRD. Although the identified mutations have not been shown to cause FSGS directly, it can be concluded that “benign familial hematuria” is a misnomer for some cases of thin basement membrane nephropathy. See Voskarides et al., pages 3004–3016.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
  • © 2007 American Society of Nephrology
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 18 (11)
Journal of the American Society of Nephrology
Vol. 18, Issue 11
November 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
This Month’s Highlights
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
This Month’s Highlights
JASN Nov 2007, 18 (11) F3; DOI: 10.1681/ASN.2007080961

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
This Month’s Highlights
JASN Nov 2007, 18 (11) F3; DOI: 10.1681/ASN.2007080961
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • BASIC RESEARCH
    • CLINICAL EPIDEMIOLOGY
    • CLINICAL RESEARCH
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • This Month's Highlights
  • This Month's Highlights
  • This Month's Highlights
Show more This Month's Highlights

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • Interferon-β Reduces Proteinuria in Experimental Glomerulonephritis
  • Glomerular Endothelial Glycocalyx Constitutes a Barrier to Protein Permeability
  • Insulin-Like Growth Factor-1 Sustains Stem Cell–Mediated Renal Repair
  • Racial Differences in End-Stage Renal Disease Rates in HIV Infection versus Diabetes
  • Mineral Metabolism and Vascular Damage in Children on Dialysis
  • COL4A3/COL4A4 Mutations Producing Focal Segmental Glomerulosclerosis and Renal Failure in Thin Basement Membrane Nephropathy
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire